Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

Clinical Trial ID NCT02319044

PubWeight™ 2.68‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02319044

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunology and Immunotherapy of Head and Neck Cancer. J Clin Oncol 2015 1.10
2 Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol 2015 0.92
3 Current clinical immunotherapeutic approaches for head and neck cancer. F1000Res 2016 0.75
Next 100